OncLive® Presents the Latest State of the Science Summit™ on Breast Cancer
17 December 2018
CRANBURY, N.J.--(BUSINESS WIRE)-- OncLive®, the leading digital provider of resources and information to oncology professionals, will host its latest State of the Science Summit™ on breast cancer. The event will take place on Wednesday Nov. 14 from 5 to 9 p.m. at the DoubleTree by Hilton Minneapolis Park Place in Minneapolis, Minnesota. The summit will feature the following co-chairs from the Mayo Clinic: Judy C. Boughey, M.D., chair, division of surgery research, and Matthew P. Goetz, M.D., co-principal investigator, Mayo Clinic Breast Cancer Specialized Program of Research Excellence.
The summit is designed for community oncologists, fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer. It will discuss triple-negative breast cancer: new insights into the biology and emerging drug therapies; HER2-positive breast cancer in the curative setting; CDK4/6 inhibitors; HR-positive breast cancer: current insights and future decisions; surgical management of the axilla in patients with node positive breast cancer treated with neoadjuvant therapy; protein beam radiation for breast cancer and current approaches for patients with lymphedema in 2018. The event will also feature a peer exchange, followed by a panel discussion and question-and-answer session.
Presenters from the Mayo Clinic include the following:
- Kimberly S. Corbin, M.D., radiation oncologist
- Roberto A. Leon Ferre, M.D., oncologist
- Oscar J. Manrique, M.D., plastic surgeon
- Ciara O’Sullivan, M.B., B.CH., family physician
State of the Science Summit™ is a premier conference series, hosted by OncLive®, that features medical experts from across the nation discussing treatment options. Each summit integrates academic and community-based physicians and health care professionals across key disciplines, from medical and surgical oncology to hematology.
Registration is free and open to all health care professionals, and food and beverages will be served. For more information and to register, visit onclive.com/meetings/soss or contact Kayla Collins at kcollins@curetoday.com.
About OncLive®
A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for the MJH Associates, Inc., Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. MJH Associates Inc. is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181108005887/en/
OncLive® Presents the Latest State of the Science Summit™ on Breast Cancer
17 December 2018
CRANBURY, N.J.--(BUSINESS WIRE)-- OncLive®, the leading digital provider of resources and information to oncology professionals, will host its latest State of the Science Summit™ on breast cancer on Wednesday, Oct. 31, from 12-4 p.m. (EDT) at the Omni William Penn Hotel in Pittsburgh, Pennsylvania. The summit will be chaired by Adam M. Brufsky, M.D., PhD, medical director, Magee-Women’s Cancer Program, part of the University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center.
Designed for community oncologists, fellows, nurse practitioners, nurses, physician assistants, researchers and other health care professionals interested in the treatment of breast cancer, this summit will discuss American Society of Clinical Oncology updates, controversies in the management of hormone receptor-positive (HR+) early stage disease, CDK4/6 Inhibitors for HR+ metastatic breast cancer, de-escalating therapy for human epidermal growth factor receptor 2-positive (HER2+) disease, locally advanced HER2+ breast cancer, novel approaches for metastatic triple-negative breast cancer and brain metastases from breast cancer. The event will also feature a peer exchange, which will be followed by a panel discussion and question-and-answer session.
Presenters from the University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center include:
- Terry L. Evans, M.D., clinical assistant professor of medicine
- Vikram Gorantla, M.D., medical oncologist and hematologist specialist
- Rachel Jankowitz, M.D., medical oncologist and hematologist
- Shannon L. Puhalla, M.D., assistant professor of medicine and medical oncologist and hematologist
- Mohammed J. Rahman, M.D., clinical assistant professor of medicine
- Priya Rastogi, M.D., vice-chair for medical affairs, National Surgical Breast and Bowel Project, and medical oncologist, Magee-Womens Hospital
State of the Science Summit™ is a premier conference series, hosted by OncLive®, that features medical experts from across the nation discussing treatment options. Each summit integrates academic and community-based physicians and health care professionals across key disciplines, from medical and surgical oncology to hematology.
Registration is free and open to all health care professionals, and food and beverages will be served. For more information and to register, visit https://www.onclive.com/meetings/soss or contact Kayla Collins at kcollins@curetoday.com.
About OncLive®
A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for the MJH Associates, Inc., Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News® and more. MJH Associates Inc. is a full-service health care communications company offering education, research, and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181022005799/en/